Unraveling the Mystery: How Weekly Delta-Radiomics on MR-Linac Can Guide Glioblastoma Treatment
Glioblastoma (GBM) poses a significant challenge in treatment due to the difficulty in distinguishing true progression (TP) from pseudoprogression (PP) during chemoradiotherapy. TP signifies [...]